Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
848.2 INR | +1.56% | +2.08% | +23.32% |
May. 06 | KKR to buy India's Healthium Medtech at $839 million valuation, sources say | RE |
Apr. 23 | Max Healthcare Institute Acquires Additional 3% Stake in Sandhya Hydro Power | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- With an expected P/E ratio at 61.88 and 51.89 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+23.32% | 9.75B | B- | ||
+18.63% | 84.11B | C+ | ||
-27.41% | 71.96B | B- | ||
+1.90% | 27.25B | C+ | ||
-9.66% | 17.31B | B | ||
-1.64% | 16.83B | A- | ||
+3.96% | 15.92B | A- | ||
+7.75% | 13.68B | B- | ||
+72.83% | 13.29B | C- | ||
+72.50% | 12.73B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MAXHEALTH Stock
- Ratings Max Healthcare Institute Limited